RxDoctor Payments Data

Mark George, MD

Psychiatry · Charleston, SCNPI 1205944154

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $10,914 of the $17,459 with a category attached, or 62.5%. Livanova USA, Inc. accounts for 67.6% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $10,818, more than ten times the $196 reported in 2019. Among psychiatry clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$17,459in general payments, 2019–2025

Across 29 payments — averaging $602.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Livanova USA, Inc.$12K
  • Abbott$5K
  • Boston Scientific$196
  • Microtransponder, Inc.$26
$314,711in research payments, 2019–2025

Across 189 payments — averaging $1665.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Livanova USA, Inc.$169K
  • Abbott$135K
  • Brainsway USA Inc$11K

What the payments were for

  • Consulting fees$2,50014%
  • Speaking & faculty fees$10,91463%
  • Travel & lodging$2,95217%
  • Food & beverage$1,0936%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Livanova USA, Inc.13$11,805
Abbott12$5,431
Boston Scientific3$196
Microtransponder, Inc.1$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,459 in reported general payments places this provider in the 95th percentile of 624 psychiatry providers in South Carolina.

See all psychiatry providers in South Carolina

Medicare billing

Part B allowed, 2024
$2,817
Medicare patients
18
Services billed
30

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Venlafaxine Hcl ErVenlafaxine Hcl26$800
Duloxetine Hcl12$244
Amitriptyline Hcl12$115
Lamotrigine22$41
Clonazepam19$39
Zolpidem Tartrate12$39
Quetiapine Fumarate12$7

Paid to pharmacies, not to this prescriber.

Other psychiatry in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →